Adicet Bio, Inc.
ACET- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720580
No open-market purchases or sales by Adicet Bio, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $52.8M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Adicet Bio, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +9 vs. Q4 2022
- Shares held
- 40.3M
- +364.6K (+0.9%) vs. Q4 2022
- Total value
- $231.3M
- −$125.3M (−35.1%) vs. Q4 2022
- New holders
- 27
- 26 more added
- Sold out
- 18
- 33 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACET on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 56 | $52.8M |
| Q1 2026 | 49 | $43.7M |
| Q4 2025 | 49 | $56.6M |
| Q3 2025 | 54 | $41.6M |
| Q2 2025 | 49 | $31.5M |
| Q1 2025 | 56 | $42.0M |
| Q4 2024 | 64 | $55.4M |
| Q3 2024 | 64 | $82.3M |
| Q2 2024 | 86 | $77.4M |
| Q1 2024 | 98 | $176.6M |
| Q4 2023 | 77 | $63.0M |
| Q3 2023 | 84 | $48.9M |
| Q2 2023 | 95 | $90.4M |
| Q1 2023 | 107 | $231.3M |
| Q4 2022 | 100 | $375.7M |
| Q3 2022 | 102 | $590.7M |
| Q2 2022 | 101 | $555.9M |
| Q1 2022 | 88 | $660.4M |
| Q4 2021 | 81 | $531.2M |
| Q3 2021 | 58 | $156.1M |
| Q2 2021 | 66 | $218.1M |
| Q1 2021 | 54 | $266.3M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Adicet Bio, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carlyle Group Inc. | 2,115,385 | $12.2M | 0.36% | +2,115,385 | New |
| Tang Capital Management LLC | 2,520,000 | $14.5M | 2.16% | +1,920,000+320.0% | Added |
| BlackRock Inc. | 2,536,802 | $14.6M | 0.00% | −8,816−0.3% | Reduced |
| Cowen and Company, LLC | 3,143,608 | $18.1M | 2.13% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 3,560,700 | $20.5M | 0.66% | 00.0% | Unchanged |
| RTW Investments, LP | 4,241,472 | $24.4M | 0.51% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 7,447,140 | $42.9M | 0.85% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −182,038−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −117,589−100.0% | Sold out |
| Ziegler Capital Management, LLC | 0 | $0 | 0.00% | −38,750−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −31,518−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −23,462−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −22,402−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −17,249−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −15,933−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −13,185−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −12,964−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −12,189−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,156−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −7,835−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −142−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −51−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |
| Telemetry Investments, L.L.C. | – | – | – | – | Not filed |